Slaughter And May Steers Life Science Co.'s $130M Financing
Immunocore Ltd. said Monday it raised $130 million in a Series B financing round steered by Slaughter and May, which the clinical-stage life sciences company will use to advance its therapies...To view the full article, register now.
Already a subscriber? Click here to view full article